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Summary
 
The cellular basis of immunological memory remains a controversial area with respect to the
identity of memory T cells and the role of persisting antigen. CD4 T cells are phenotypically
divided by the expression of high and low molecular weight isoforms of CD45, surface markers
that are frequently used to identify “naive” (CD45R
 
high
 
) and “memory” (CD45R
 
low
 
) subsets.
The latter subset responds rapidly in antigen recall assays but paradoxically has a short life span,
a property that is difficult to reconcile with long-term memory. The present study examines
these issues using a DTH (delayed-type hypersensitivity) model in which contact sensitivity to
dinitrochlorobenzene (DNCB) was transferred to athymic nude rats by recirculating CD4 T cell
subsets defined in the rat by the anti-CD45RC mAb OX22. As expected, CD45RC
 
1
 
 (but not
RC
 
2
 
) CD4 T cells from normal unprimed rats transferred a DNCB-specific DTH response,
whereas, 4 d after sensitization the CD45RC
 
2
 
 (memory) subset alone contained the DNCB
reactivity. However, when donor cells were collected from thymectomized rats sensitized two
mo earlier, DNCB-specific responses were transferred by both CD45RC
 
2
 
 and RC
 
1
 
 subsets
suggesting that many of the latter had developed from cells with a memory phenotype. This
was confirmed when CD45RC
 
2
 
 CD4 T cells from 4-d primed rats were parked in intermedi-
ate nude recipients and recovered 2 mo later. DNCB-specific activity was now found wholly
within the CD45RC
 
1
 
 “revertant” subset; the CD45RC
 
2
 
 CD4 T cell population was devoid
of activity. Importantly, we found that the total switch-back from CD45RC
 
2
 
 to RC
 
1
 
 could
be prevented, apparently by persisting antigen. The results indicate that there are two function-
ally distinct categories of memory T cells: one, a short-lived CD45R
 
low
 
 type which orchestrates
the rapid kinetics, the other, a longer-lived CD45R
 
high
 
 revertant which ensures that immuno-
logical memory endures.
 
A
 
hallmark of the immune response is memory, the abil-
ity to recall an earlier encounter with specific antigen,
often years later, by producing a faster and larger response.
A definitive investigation by Gowans and Uhr (1) using adop-
tive transfer, squarely laid the basis of immunological mem-
ory with recirculating lymphocytes recovered from the
thoracic duct. At the time, it was generally accepted that im-
munological memory was vested in lymphocytes, which,
after an initial antigen encounter, were imbued with the
quality of long life (2). This view was challenged by the ex-
periments of Gray and colleagues (3, 4) that suggested that
the survival of both B and T memory cells depended criti-
cally on the persistence of antigen. The role that persisting
antigen plays in maintaining memory has been reexamined
recently for CD8 T cells specific for viruses (5–9). The bal-
ance of evidence suggests that in the absence of antigen,
specific CD8 T cells may survive, although some argue that
protective immunity by CD8 T cells ultimately depends on
the persistence of antigen (8, 9). To what extent CD4 T
cell memory is governed by residual antigen has not been
resolved.
T cells stimulated by antigen undergo a number of well-
described changes. The question is which of these, if any, are
retained and can be used to identify memory T cells. The in-
creased expression of CD44 after antigen stimulation has been
used to identify CD8 and CD4 memory T cells in mice (10).
In some mouse strains, but not others (11), CD44 remains
high on CD8 T cells for many months (9, 11, 12), but the
high density is not maintained on CD4 T cells (12). The
idea that memory T cells exclusively recirculate to lymph
nodes via afferent lymphatics (13, 14) is not supported by
later studies that show that cells with a memory phenotype
readily cross high endothelial venules within lymph nodes
(15, 16). The downregulation of L-selectin (CD62L) (9,
17–19) and the increased expression of the 
 
a
 
4
 
 integrin sub-
unit (CD49d) (9, 19) that alters migration have also been
used as markers of memory T cells, but modulation of these
adhesion molecules is reversible and closely linked with the
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activation state of the cell (9, 12, 18). The high and low
molecular weight isoforms of CD45R are consistently
used to identify naive and memory CD4 (but not CD8
[18]) T cells (20–22). CD45R
 
low
 
 CD4 T cells have rapid in
vitro antigen recall responses (23, 24) and are able to help
primed B cells produce antibody (21, 22), functions which
suggest memory T cells. Equating the CD45R
 
low
 
 pheno-
type with memory, however, poses a dilemma. Whereas
CD45R
 
high
 
 (naive) T cells are nondividing long-lived cells,
the CD45R
 
low
 
 subset tends to be a rapidly dividing, short-
lived population (12, 27–29). Furthermore, CD45R
 
low
 
 CD4
T cells upregulate Fas (CD95) and downregulate bcl-2 (30,
31), a phenotype associated with impending apoptosis. It is
difficult to reconcile a short-lived cell with the fact that im-
munological memory endures.
The antigen-driven switch from CD45R
 
high
 
 to CD45R
 
low
 
(32, 33) was initially considered to be one-way (20, 23,
24). In vivo studies in rats (34) and subsequently in humans
(27) indicated that CD45R
 
low
 
 isoform expression was re-
versible. Although the time-frame for humans may be
longer (29), the speed with which rat CD4 T cells could
revert in vivo from CD45R
 
low
 
 to CD45R
 
high
 
 was striking
(28); a majority of CD4 T cells had switched back to the
CD45R
 
high
 
 phenotype within a week. This implied that
T cells that have previously encountered antigen, i.e.,
memory T cells, should be found in both CD45R
 
low
 
 and
CD45R
 
high
 
 subsets. Direct evidence for this supposition is
lacking. It has also been suggested that persisting antigen
could control CD45R isoform expression (35), but this is-
sue has not yet been addressed for CD4 T cells.
In the present investigation, we used a delayed-type hy-
persensitivity (DTH)
 
1
 
 model in which a specific response
to the contact sensitizing agent 2,4-dinitrochlorobenzene
(DNCB) could be adoptively transferred to athymic nude
rats by recirculating CD4 T cells. By using allotype-marked
donor cells we were able to follow changes in CD45R iso-
form expression after transfer. The results demonstrated
that antigen-experienced CD4 memory T cells revert en
masse (default) from CD45R
 
low
 
 to CD45R
 
high
 
. Importantly
though, residual antigen could prevent the total switch-
back from occurring.
 
Materials and Methods
 
Rats.
 
Congenic allotype-marked PVG-RT1
 
u
 
-RT7
 
b
 
 and athy-
mic PVG-RT1
 
u
 
-rnu/rnu(RT7
 
a
 
) nude rats were bred and main-
tained under conventional conditions in the Animal Unit, Uni-
versity of Manchester Medical School, and used at 2–3 mo of age.
In some experiments PVG-RT1
 
u
 
 -RT7
 
b
 
 rats were thymectomized
at 4–6 wk of age and rested for 1 mo before use.
 
Induction and Measurement of Contact Sensitivity.
 
Rats were sen-
sitized by applying 200 
 
m
 
l of a 5% solution of DNCB (BDH
Chemicals Ltd., Poole, UK) in ethanol on the shaven abdomen.
On day 4 after sensitization rats were challenged by applying to
both sides of the ear a total of 40 
 
m
 
l of a 1% solution of DNCB
(400 
 
m
 
g) in ethanol to the left ear and 40 
 
m
 
l of ethanol only to
the right ear. Ear thickness was measured 24 h after challenge
(time of maximum response) using a spring-loaded engineer’s mi-
crometer (“ODITEST” ODI OOT; Kröplin GMBH, Hessen,
Germany) by full release of the spring. The response was recorded
as the difference in ear thickness between the left and right ears
and expressed as 
 
m
 
m 
 
6
 
 SD. Differences between groups were
compared using Student’s 
 
t
 
 test.
 
Antibodies.
 
The following mAbs were used for cell separation
and phenotyping: OX6 (anti-class II MHC), OX7 (anti-Thy-1),
OX8 (anti-CD8), OX12 (anti-Igk chain), OX22 (anti-CD45RC),
OX40 (against a molecule with some homology to CD40 and
nerve growth factor receptor; present on activated CD4 T cells
[36]), W3/25 (anti-CD4), R73 (anti-
 
ab
 
 TcR) and 8G6.1 (rat
anti-RT7
 
b
 
;
 
 
 
a
 
 
 
gift from Dr. Simon Hunt, Oxford). Mouse mAbs
were detected with FITC-conjugated F(ab
 
9
 
)
 
2
 
 rabbit anti–mouse
Ig (Dako Ltd., High Wycombe, UK) absorbed extensively against
rat Ig. Biotinylated mAbs were detected with phycoerythrin-
streptavidin (Sera-lab, Cowley, UK). Mouse mAbs were purchased
from Serotec (Bicester, Oxon, UK) or produced as ascites in the
laboratory by injecting the relevant hybridoma into pristane-
primed Balb/c mice. The R73 clone (37) was a gift from Prof. T.
Hünig (Würzburg, Germany). Other hybridoma cell lines were
provided by ECAAC (Porton Down, UK). The dual fluores-
cence staining technique used to phenotype allotype-marked
(RT7
 
b
 
) donor cells after transfer to wild-type (RT7
 
a
 
) recipients
was described elsewhere (28).
 
Cell Separation.
 
Lymphocytes from lymph nodes (LN) or the
thoracic duct (TDL) were incubated for 30 min at 4
 
8
 
C with satu-
rating concentrations of OX6, OX8, OX12, and OX7 (to re-
move B cells, CD8 T cells and CD45RC
 
2
 
 Thy-1
 
1
 
 recent thymic
emigrants [38]), washed in Dulbecco’s phosphate buffered saline
supplemented with mineral salts A and B (Oxoid Ltd., Basing-
stoke, UK) plus 2% fetal calf serum and mixed on a roller/rocker
for 30 min at 4
 
8
 
C with goat anti–mouse IgG–coated Biomag
 
Ô
 
particles (Metachem Diagnostics Ltd., Piddington, UK). The re-
sulting rosettes were removed from suspension by a magnet (Dy-
nal Ltd., New Ferry, UK) applied to the wall of the container.
The remaining CD4 T cells (
 
.
 
98% CD4
 
1
 
; FITC-conjugated
W3/25) were incubated with saturating concentrations of mAb
OX22 (anti-CD45RC), positively selected onto goat anti-mouse–
coated Biomag
 
Ô
 
 particles, the cell/particle rosettes washed free
of unbound CD45RC
 
2
 
 
 
cells, resuspended at appropriate concen-
trations and the CD45RC
 
1
 
 CD4 T cells injected intravenously
with particles attached. The unbound nonrosetting cells were
restained with OX22, mixed with Biomag
 
Ô
 
 particles and de-
pleted of mAb-stained cells as above by 2 or 3 rounds of magnetic
adhesion. The CD45RC
 
2
 
 CD4 T cells (
 
.
 
98% pure) were injected
intravenously.
 
Adoptive Transfer of DNCB Response.
 
Purified CD4 T cells or
CD45RC
 
1
 
 and RC
 
2
 
 subsets were collected from allotype-
marked (RT7
 
b
 
) PVG-RT1
 
u
 
-RT7
 
b
 
 euthymic donors and a stan-
dard dose of 10
 
 3 
 
10
 
6
 
 T cells transferred intravenously to PVG-
RT1
 
u
 
 (RT7
 
a
 
) athymic nude rats. Recipients were skin-sensitized
3 wk after transfer, unless otherwise indicated, ear-challenged 4 d
later and ear thickness always measured after 24 h.
 
Results
 
Kinetics of Response in Euthymic Rats.
 
The DNCB-induced
DTH response, recorded as the difference between left
(DNCB in ethanol) and right ears (ethanol only control),
was always recorded 24 h after ear-painting, i.e., challenge.
 
1
 
Abbreviations used in this paper:
 
 DNCB, 2,4-dinitrochlorobenzene; DTH,
delayed-type hypersensitivity; TDL, thoracic duct lymphocytes. 
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To determine the kinetics of the response, rats were sensi-
tized, i.e., DNCB applied to the abdomen, and ear-chal-
lenged on days 1–18. The maximum response to challenge
(410 
 
m
 
m 
 
6
 
 82) was induced 4 d after primary sensitization
and declined if challenge was delayed further. The response
to DNCB subsided rapidly to a plateau of around 120 
 
m
 
m
by day 8, a typical response pattern reported by others (39).
 
Adoptive Transfer to Nude Recipients.
 
A series of experi-
ments showed that the DNCB response could be adop-
tively transferred to athymic PVG-RT1
 
u
 
 nude rats by whole
LN cells or by CD4 T cells purified from TDL of un-
primed PVG-RT1
 
u
 
 rats. To standardize the procedure, we
opted to transfer 10
 
 3 
 
10
 
6
 
 T cells 3 wk before sensitization,
an interval designed to allow donor T cells to spontane-
ously proliferate in nude recipients (40). Ears were always
challenged 4 d after sensitization and ear thickness mea-
sured 24 h later. The assay was designed to identify the
presence or absence of DNCB-specific T cells in the cell
inoculum and, within limits, the size of the response was
cell dose dependent (data not shown).
In the rat CD4 T cells are divided into two functionally
distinct subsets by the anti-CD45RC mAb OX22 (25, 26)
that detects an epitope on the C exon product of CD45R
(41). Exon C is one of three (A, B, or C) that can be vari-
ably spliced out of the CD45R molecule by posttransla-
tional mRNA transcription (42, 43) and is expressed
(CD45RC
 
1
 
) by three-quarters of the rat CD4 T cell popu-
lation (25, 34). T cells emerge from the thymus (recent thymic
emigrants, RTE) with the phenotype CD45RC
 
2
 
 Thy-1
 
1
 
and develop within a week into mature CD45RC
 
1
 
 Thy-1
 
2
 
T cells (38, 44). Thus, CD45RC
 
2
 
 CD4 T cells in the pe-
riphery are a mixture of immature Thy-1
 
1
 
 RTE (40%) and
mature Thy-1
 
2
 
 antigen-experienced T cells (60%) (45) de-
rived from the CD45RC
 
1
 
 subset (32, 38). To avoid ambi-
guity, RTE were always removed from the CD45RC
 
2
 
subset during purification.
Using T cell subsets purified from TDL of unprimed rats,
the DNCB response was transferred to nude recipients by
the CD45RC
 
1
 
 subset alone, as expected; the CD45RC
 
2
 
subset from unprimed rats lacked T cells specific for
DNCB (Fig. 1 
 
a
 
). To show that specific antigen altered iso-
form expression, CD45RC
 
1
 
 and RC
 
2
 
 subsets were puri-
fied from TDL of DNCB-primed rats 4 d after sensitiza-
tion, a time at which ear-challenge would normally induce
immediate ear swelling. Fig. 1 
 
b
 
 shows that the DNCB
response was now transferred with the CD45RC
 
2
 
 subset
alone. Note, however, that in contrast with the experiment
in Fig. 1 
 
a
 
, nude recipients in Fig. 1 
 
b
 
 were ear-challenged
immediately (instead of at 3 wk) after cell transfer, a proto-
col that also demonstrated that the CD45RC
 
2
 
 subset was
responsible for the effector stage of the response. Although
recently stimulated, the DNCB-responding T cells were
not in a state of hyperacute activation. For example, the
purified CD45RC
 
2
 
 subset displayed size and granularity
characteristics that were indistinguishable from small lym-
phocytes (15). Furthermore, depleting the CD45RC
 
2
 
 sub-
set of OX40
 
1
 
 cells, a marker of activated T cells in the rat
(36), did not significantly reduce the adoptively transferred
DTH response (Fig. 1 
 
b
 
). This evidence is compatible with
the notion that the low molecular weight isoform of CD45R
marks memory T cells (20–24, 32, 33).
Antigen-specific CD45RC2 CD4 T Cells Revert to
CD45RC1. Investigations based on whole cell popula-
tions, but with no regard for antigen specificity, have indi-
cated that CD45RC2 T cells (and comparable CD45RA2
RO1 T cells in humans) will reexpress with time the high
molecular weight isoform (CD45RC1 in rats; CD45RA1
in humans) both in vitro (46–49) and in vivo (27–29, 34,
45). However, there is no clear demonstration that such a
reversion (from a memory to a naive phenotype) will occur
within an antigen-specific population in vivo. Therefore,
we determined whether DNCB-specific memory T cells
remained CD45RC2 or could revert to CD45RC1 with
time. To exclude a contribution of newly generated naive
CD45RC1 CD4 T cells from the thymus, animals were thy-
mectomized. 2 mo after sensitization, CD45RC1 and RC2
subsets were obtained from TDL and adoptively transferred
to nude recipients (Fig. 2 a). Over half the DNCB-specific
activity was now found within the CD45RC1 subset (Fig.
2 b), suggesting that antigen-specific T cells had switched
back from a CD45RC2 state. It was also clear that at 2 mo,
the CD45RC2 subset still retained a large population of
DNCB-specific T cells.
This experiment does not exclude the possibility that the
response generated by the CD45RC1 subset at 2 mo could
have originated from residual naive T cells not stimulated
during the primary sensitization. We asked, therefore, how
efficient was the sensitization in converting naive T cells to
a CD45RC2 phenotype. At day 4 after sensitization CD4
Figure 1. DNCB-specific CD4 T cells are found exclusively in the
CD45RC1 subset of unprimed rats but after sensitization reside in the
CD45RC2 subset. The latter transfers the effector stage of the DTH re-
sponse. (a) PVG-RT1u athymic nude rats received no cells (control) or
were injected intravenously with 10 3 106 CD45RC1 or 10 3 106
CD45RC2 CD4 T cells, purified from TDL of unprimed PVG-RT1u-
RT7b rats. Nude rats were sensitized after 3 wk, ear-challenged 4 d later,
and ear thickness measured after 24 h. Histograms represent means 6 SD
4, 6, or 4 rats per group (left to right). Test of significance: control vs
CD45RC1, P ,0.001. (b) PVG-RT1u nude rats received no cells (control)
or were injected with 110 3 106 CD45RC1, 50 3 106 CD45RC2 or 50 3
106 CD45RC2/OX402 CD4 T cells purified from LN or TDL of 4-d
sensitized PVG-RT1u-RT7b rats. LN and TDL results were pooled as no
difference was found between them. Rats were ear-challenged immedi-
ately after cell transfer and ear thickness measured 24 h later. Histograms
are means 6 SD of 4, 9, 7 or 4 rats per group (left to right). Test of significance:
control vs CD45RC1, NS (not significant P .0.05); vs CD45RC2 or
CD45RC2/OX402, P ,0.001; CD45RC2 vs CD45RC2/OX402, NS.770 Two Types of CD4 Memory T Cells
T cells were separated into CD45RC1 and RC2 subsets
and transferred to nude recipients (Fig. 2 c), but not imme-
diately challenged (unlike the experiment in Fig. 1 b). 2 mo
later the reconstituted nude recipients were sensitized and
ear-challenged. The results demonstrated that virtually all
the DNCB-specific activity at day 4 after priming was con-
fined within the CD45RC2 subpopulation (Fig. 2 d); five
times as many CD45RC1 CD4 T cells failed to transfer a
significant DTH response. Thus, by day 4, the CD45RC1
subset was essentially devoid (clonally depleted) of DNCB-
specific T cells. Hence, the reappearance of DNCB activity
within the CD45RC1 subset at 2 mo strongly suggested
that specific T cells reverted from the CD45RC2 subset.
To investigate more conclusively whether antigen-expe-
rienced memory T cells can revert from CD45RC2 to
RC1, highly purified CD45RC2 CD4 T cells (.98.0%
pure) from 4-d sensitized rats were “parked” in athymic
nude recipients until retransfer (Fig. 3, left protocol). Ap-
proximately 60% of the donor-derived population (carry-
ing the RT7b allotype marker) subsequently re-expressed
the high molecular weight isoform (CD45RC1) (e.g., 34,
35). Donor-derived CD45RC1 revertants and CD45RC2
CD4 T cells were recovered from TDL of the intermediate
nude rats after 2 mo, purified and re-transferred to secondary
nude recipients. Surprisingly, the DNCB-specific response
was contained entirely within the CD45RC1 subset (Fig. 3 a).
No specific DTH activity remained within the CD45RC2
subset; an equal number of retransferred CD45RC2 CD4
T cells gave a response that was indistinguishable from the
negative control. Clearly antigen-specific memory T cells
survived in the complete absence of antigen, but all ex-
pressed the CD45RC1 phenotype.
Because the switch-back was so decisive, we asked
whether the DNCB-specific activity remaining in the
CD45RC2 subset of the previous experiment (Fig. 2 a)
could have been caused by persisting antigen. To test this
idea, CD45RC2 CD4 T cells (.98.5% pure) were trans-
ferred into intermediate nude recipients as before, except
that the animals were ear challenged on the day of transfer.
The T cell–injected nude rats were those from the experi-
ment in Fig. 1 b; they received no other source of antigen.
7 mo later donor-derived CD4 T cells were recovered
from TDL, purified into CD45RC1 and RC2 subsets, and
transferred into secondary nude recipients. After 3 wk,
Figure 2. Evidence that antigen-experienced
DNCB-specific CD45RC2 CD4 T cells revert to a
CD45RC1 phenotype in DNCB-sensitized rats.
Donor rats (thymectomized) were sensitized with
DNCB, TDL collected 2 mo (a, b) or 4 d (c, d) later,
separated into CD45RC1 and CD45RC2 subsets
and 10 3 106 (or 50 3 106 as indicated) T cells trans-
ferred to athymic nude rats. Recipients were recon-
stituted for 3 wk (b) or for 2 mo (d), sensitized, ear-
challenged 4 d later and ear thickness measured after
24 h. Histograms represent means 6 SD of 3 or 4
rats in each group. Test of significance: (b)
CD45RC1 vs CD45RC2, P ,0.02.771 Bunce and Bell
these animals were sensitized and ear challenged in the stan-
dard way (Fig. 3, right protocol). Again, a majority of anti-
gen-experienced memory T cells reverted to a CD45RC1
phenotype. However, a significant number of DNCB-specific
T cells were still found within the CD45RC2 subset. This
suggests that residual antigen was preventing antigen-expe-
rienced CD45RC2 T cells from defaulting to a CD45RC1
state. Furthermore, the results indicate that there are two
distinct categories of memory CD4 T cells, one CD45RC2
the other CD45RC1.
CD4 T Cell Infiltration. The ears of DNCB challenged
nude recipients were examined immunohistochemically for
the presence of donor-derived CD4 T cells, i.e., those
staining positive for the RT7b allotype marker. Represen-
tative samples from the experiment in Fig. 3 a are illustrated
in Fig 4. The ears of uninjected nude controls, which showed
no net increase in ear thickness, were devoid of allotype-
marked cells. In contrast, recipients’ ears of CD45RC1 re-
vertants were heavily infiltrated; donor T cells were abun-
dant in the greatly thickened dermis and epidermis. Curi-
ously, all samples in this group had numerous consolidated
foci on the outer surface of the epidermis containing dense
collections of polymorphonuclear leukocytes. The increased
ear thickness, induced by the CD45RC1 revertants and
measured in situ, was clearly visible in cross section (Fig. 4,
insets). The ears of nude rats injected with nonresponsive
CD45RC2 CD4 T cells, lacking DNCB-specific T cells,
were also infiltrated with donor-derived CD4 T cells, but
to a lesser extent. Clearly, both DNCB-specific and non-
specific CD4 T cells had ready access to the ear, but only
the former induced changes (presumably by cytokine re-
lease) that caused a local increase in ear thickness.
Response of CD45RC1 CD4 T Cell Revertants. An im-
portant question arises as to whether CD45RC1 revertants
display characteristics similar to or different from truly na-
ive antigen-inexperienced CD45RC1 T cells. Available evi-
Figure 3. Antigen-experienced CD45RC2
CD4 T cells that transfer a DNCB-specific
DTH response revert completely to CD45RC1
in nude recipients, a change that was inhibited
by residual antigen. CD45RC2 CD4 T cells
were purified from TDL of rats sensitized 4 d
before with DNCB and adoptively transferred
into intermediate nude recipients. TDL were re-
covered (a) 2 mo later (left protocol) or (b) 7 mo
later from DNCB ear-challenged intermediate
nude rats (right protocol), separated into CD45RC1
revertants and CD45RC2 CD4 T cells and
transferred (10 3 106 cells/recipient) into sec-
ondary nude rats. These were sensitized with
DNCB after 3 wk and ear-challenged 4 d later.
Ear thickness was measured after 24 h. Histo-
grams are means 6 SD of 4, 4, 2, 4, and 4 (left to
right) rats per group. Test of significance: (a)
control vs CD45RC1, P ,0.001; CD45RC1
vs CD45RC2, P ,0.01; (b) CD45RC1 vs
CD45RC2,  P  ,0.01.772 Two Types of CD4 Memory T Cells
dence suggests that CD45RC1 “revertants” behaved like
unprimed T cells. For example, when revertants were col-
lected from 2-mo primed thymectomized rats, transferred
to nude recipients and challenged immediately (a measure
of effector cell potential), they were unable to evoke a DTH
response (CD45RC1: 74 mm 6 17; control: 62 mm 6 15).
In addition, the kinetics of the DTH response in sensitized
rats was comparable with that of rats resensitized 6.5 or 8 wk
after primary sensitization. Once- or twice-primed rats were
ear challenged on various days after sensitization. When com-
pared with the once-primed animals, the kinetics of the
DNCB responses in twice-primed rats were remarkably
similar (Fig. 5). The peak responses occurred at day 4 in
both once- and twice-primed rats suggesting, but not prov-
ing, that CD45RC1 revertants responded with primary ki-
netics. There was, however, a significant increase in the re-
sponse at day 3 after secondary sensitization (P ,0.001).
Although not proven, this early increase could be due to
DNCB-specific CD45RC2 CD4 T cells in sensitized rats
being retained in an upregulated state by persisting antigen.
Discussion
The main conclusions of the present investigation were
(a) that antigen-specific CD4 T cells, which expressed a low
molecular weight isoform (CD45RC2) after antigen en-
counter, reexpressed the high molecular weight isoform
(CD45RC1) in large numbers, (b) that, in the absence of
antigen, the switch back was total and (c) that persisting an-
tigen could prevent reversion. Since both CD45RC1 and
RC2 subsets represent functionally distinct populations, the
results indicate that there are two major types of antigen-
experienced CD4 memory T cells.
CD4 T cells are pivotal in the immune response in that
they control the development and activation of B cells, CD8
T cells, macrophages and other inflammatory cells. Assessing
the response of memory CD4 T cells in vivo is conse-
quently indirect (antibody production, cytotoxicity, intra-
cellular killing, inflammation, infiltration, swelling). Although
primary sensitization occurs centrally within draining LNs
(51, 52), we presume that the ear swelling measured here is
the culmination of factors released by antigen-specific CD4
T cells exposed locally to DNCB. A number of studies in
mice have shown that contact sensitivity is mediated by
CD4 T cells (39, 53), although recent investigations have
linked the effector stages with CD8 T cells (54). In our ex-
periments the effector stage of the response was transferred
to nude rats by antigen-experienced CD45RC2 CD4 T cells
and donor-derived CD4 T cells were identified in large
numbers within the inflamed ears (Fig. 4). We have not
rigorously excluded a role for CD81 T cells, but, if in-
volved, they must be of extrathymic origin (55) and subser-
vient to CD4 T cells.
In unprimed naive rats, DNCB-specific CD4 T cells were
found only within the CD45RC1 subset; the CD45RC2
compartment was devoid of reactivity. In contrast, after
acute sensitization, DNCB-primed T cells were concentrated
in the CD45RC2 population. Neither of these observa-
tions was unexpected and confirm what others have shown
(9, 18, 32, 33). What has not been highlighted before was
the completeness of the isoform switch. It was known from
earlier work that antigen rapidly recruited specific lympho-
cytes into secondary lymphoid tissues, effectively removing
them for a period of time from the recirculating pool (56–
58). Our evidence suggested that recruitment was highly effi-
cient and that the entire DNCB-specific population switched
from CD45RC1 to RC2 by day 4 after sensitization. Con-
sequently, the CD45RC1 subset became negatively selected,
devoid of DNCB-specific T cells. Nude recipients injected
with this depleted CD45RC1 subset never developed a
DNCB response, even many months after reconstitution.
One of the primary aims of the investigation was to de-
termine whether antigen-specific T cells, once induced
to express the low molecular weight isoform, returned
to a CD45RC1 naive phenotype. That DNCB-specific
CD45RC2 CD4 T cells did revert was shown in two dif-
Figure 4. Donor-derived CD4 T cells infiltrate the ears of DNCB-challenged, T cell reconstituted nude rats. Ears from uninjected nude rats (Control)
or from nude rats injected with CD45RC1 revertants or with unresponsive CD45RC2 T cells (all taken from rats of experiment Fig. 3a at 48 h) were snap
frozen, sectioned, and stained for the presence of RT7b allotype-marked donor cells as described elsewhere (50). There was a heavy infiltrate of donor-
derived CD4 T cells in the dermis (de) and epidermis (ep) of recipients reconstituted with CD45RC1 revertant T cells and the surface of the epidermis
showed necrotic foci (*) containing numerous polymorphonuclear leukocytes. In cross section, the ears were swollen, more cellular, and increased in
thickness compared with ears from control and CD45RC2 T cell–injected nude rats (insets). The ears of the latter recipients showed a modest infiltrate of
donor-derived cells but were not swollen. Original magnification 380; inset 310. cu, cutis; ca, cartilage; mu, muscle. The immunostaining and photo-
graphs were kindly provided by K. Bankes-John and Jürgen Westermann, Hannover, Germany.773 Bunce and Bell
ferent systems: thymectomized rats and subset-reconsti-
tuted nude recipients.
The total switch from CD45RC1 to RC2 4 d after sen-
sitization, followed by a return of the majority of DNCB-
specific T cells to the CD45RC1 state 2 mo later (Fig. 2 a),
clearly argues for a switch-back. Although unlikely, it was dif-
ficult to exclude the possibility, first, that a few CD45RC1
DNCB-specific T cells escaped priming and formed the ba-
sis of the revertant population. Second it was suggested from
DNA (Brdu) labeling studies that CD45RBhigh T cells (the
mouse equivalent of rat CD45RC1 T cells) might divide
without changing phenotype (12). Third, it was not possi-
ble to exclude the effect of persisting antigen. Therefore,
the switch-back was tested in more decisive experiments.
Highly purified 4 d primed CD45RC2 CD4 T cells were
parked in intermediate nude rats in which the influence of
persisting antigen could be eliminated. The unambiguous
and complete reversion of DNCB-specific T cells in the
absence of antigen exceeded our most optimistic expecta-
tions. Using intermediate nude recipients, we also found that
ovalbumin-primed CD45RC2 CD4 T cells which helped
primed B cells produce specific antibody, reverted to a
CD45RC1 state (Bell, E.B., S. Hayes, and C. Bunce,
unpublished observation). More importantly, though, the
DNCB studies showed for the first time that residual anti-
gen could prevent CD45RC2 to RC1 reversion.
It was remarkable that a nonreplicating antigen contin-
ued to exert an influence on the DNCB-specific CD4 T
cell population even 7 mo after application. This observa-
tion could explain the difficulty, e.g., in a human context,
of demonstrating that antigen-experienced CD45RO T
cells revert to a CD45RA state. In practice the organism
may never rid itself of residual antigen. Others have hy-
pothesized that once primed, T cells may be readily acti-
vated and could be maintained in a CD45Rlow memory
state by restimulation with low affinity cross-reacting anti-
gens (59). The fact that the DNCB-specific population re-
verted in its entirety to a naive phenotype indicates that, at
least for this antigen, putative cross-reacting antigens played
no demonstrable role. Given that specific antigen was found
to exert a long-term effect, it is not necessary to hypothe-
size a role for cross-reacting antigen.
Earlier evidence from whole populations indicated that
isoform exchange was cyclic (28). Thus, a switch between
CD45RC1 and RC2 could occur more than once, perhaps
governed by chance encounter with retained antigen. This
proposed pattern of events coincides with the known turn-
over of the two subsets (12, 28). The CD45RBhigh subset in
mice was shown to be comprised largely of long-lived cells
in interphase, whereas a majority of the CD45RBlow frac-
tion was rapidly dividing and incorporated Brdu (12). A
small but significant fraction of resting CD45RBhigh cells
was also labeled with Brdu (12, 60). The present results
would indicate that the labeled CD45RBhigh cells were
likely to be revertants, rather than “T cells which divided
without losing their naive phenotype” (12). Life span stud-
ies in humans based on cells bearing radiation-induced di-
centric chromosomes (27, 29) and in rats after the loss of
transferred allotype-marked CD4 T cells (28) both reached
the same conclusion: CD45RA1 (human) or CD45RC1
(rat) T cells were long-lived; CD45RA2 (CD45RO1) or
CD45RC2 T cells were short-lived. It is important to note
that turnover of human lymphocytes was measured in
months, not days as in rodents, reflecting the considerable
difference in life span between these species.
If CD45Rlow T cells were to be the sole purveyors of
memory, it becomes difficult to reconcile the long duration
of functional memory in vivo with the known characteris-
tics of the CD4 CD45Rlow subset. We think the present
observations resolve this paradox. There are two types of
CD4 memory T cells: (a) memory T cells (CD45Rlow) that
respond quickly (24), upregulate adhesion molecules, mi-
grate differently (13–15, 21) but survive less well (12, 27–
31) and (b) the antigen-experienced revertants that regain a
full resting state and migrate conventionally but endure.
The former contributes the qualitative attribute (speed) of
the classical memory response, the latter only the quantita-
tive element. This idea (35) has also been supported by
others (61).
What, therefore, is the nature of the CD45RC1 rever-
tants? Have they been changed by their previous encounter
with antigen? We have been unable to find any phenotypic
or functional characteristics that distinguish the revertants
from CD45RC1 CD4 T cells that have never seen antigen.
For example CD45RC1 revertants regain their ability to in-
duce graft-versus-host responses (34, 46). CD44 and L-selec-
tin (CD62L), markers associated with activated CD8 mem-
ory T cells (6, 9, 10, 18, 19), were not decisive in the rat.
CD44 expression in the rat was not significantly upregu-
Figure 5. The kinetics of the DNCB response in once- or twice-
primed rats is similar. Rats were sensitized with DNCB on day 0 and ear-
challenged at various times after sensitization (closed circles) or were sensi-
tized with DNCB a second time at 6.5 wk (open triangles) or 8 wk (open
circles) and ear-challenged at the times indicated. Each point is the mean 6
SD of 3–5 rats. The twice-primed rats were thymectomized before sensi-
tization.774 Two Types of CD4 Memory T Cells
lated in the CD45RC2 CD4 T cell subset and was similar
in this regard with certain mouse strains (11). With respect
to L-selectin, essentially all CD45RC1 CD4 T cells, which
would include revertants, and two thirds of the CD45RC2
subset were L-selectinhigh (mAb HRL-1 and HRL-2 [62]).
The populations of CD45RC2 T cells defined by high and
low expression of L-selectin are under investigation. A
detailed assessment of mRNA encoding splice variants of
CD45R (using reverse transcription and the polymerase
chain reaction) showed that revertants were identical with
truly naive CD4 T cells, generated from recent thymic em-
igrants (Hargreaves, M., and E.B. Bell, manuscript submit-
ted for publication). When DNCB-primed rats were resensi-
tized, the kinetics of the new response were the same as
those in once-primed animals (Fig. 5). However, we do not
know whether the revertant T cells remained committed to
the cytokine profile (Th1 or Th2) induced by DNCB. Oth-
ers reported that the cytokine patterns of resting memory
CD4 T cells were permanently polarized (22). However, the
antigen-primed transgeneic T cells used in that study re-
mained CD45RBlow and never returned to the CD45RBhigh
phenotype described in the present investigation.
There is no theoretical constraint that would conflict
with the contention that revertant memory T cells adopt
their former naive characteristics. Revertants would qualify
as memory cells by virtue of the fact that they have seen an-
tigen and clonally expanded. Recent experiments (Bunce,
C., and  E.B. Bell, unpublished) showed that DNCB-spe-
cific CD4 T cells increased three- to fivefold among the
CD45RC1 revertant population. An increase in frequency
of antigen-specific T cells after antigen stimulation was clearly
documented for CD8 T cells (63–65) and many of these
down-regulated activation molecules with time (9, 18, 19).
The present results afford a new perspective on the role
of persisting antigen in the maintenance of immunological
memory. Persisting antigen ensures an accelerated response
by CD45Rlow T cells and the ability of these to migrate
into non-lymphoid sites, qualities important for functional
protection against, e.g., viruses (9, 65). Should antigen dis-
appear entirely, memory T cells simply revert to a quies-
cent state and decay more slowly; for some infections,
quantity may be more important than speed. Immunity is
not, of course, always permanent and failure to protect
could be a consequence of T cells merely downregulating
their activation state or be due to the eventual loss of the
CD45Rhigh resting population itself. We suggest, therefore,
that the amount of persisting antigen could apportion the
distribution of specific T cells between the two subsets and
determine the precise character of the secondary response,
balancing the desirability of rapid onset against the need to
retain a high frequency of specific cells with which to com-
bat an infrequent antigenic insult.
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